Evaluación de la función efectora de Linfocitos T activados por péptidos provenientes de Mycobacterium Tuberculosis H37rv en Macrófagos Infectados por el Patógeno

La tuberculosis (TB) es una enfermedad infecto contagiosa, causada principalmente por Mycobacterium tuberculosis (Mtb), la cual sigue siendo una enfermedad de alto impacto en salud pública. Actualmente la única vacuna avalada por la OMS contra la TB, se fundamenta en un bacilo atenuado de Mycobacter...

Full description

Autores:
Vergara Vanegas, Valentina
Tipo de recurso:
Trabajo de grado de pregrado
Fecha de publicación:
2021
Institución:
Colegio Mayor de Cundinamarca
Repositorio:
Repositorio Colegio Mayor de Cundinamarca
Idioma:
spa
OAI Identifier:
oai:repositorio.unicolmayor.edu.co:unicolmayor/2831
Acceso en línea:
https://repositorio.unicolmayor.edu.co/handle/unicolmayor/2831
Palabra clave:
Linfocitos
Patógeno
Enfermedad
Salud pública
Tuberculosis
Mycobacterium tuberculosis H37Rv
Vacuna
Macrófagos
Péptidos sintéticos
Co-cultivo
Oxido nítrico
Rights
closedAccess
License
Derechos Reservados - Universidad Colegio Mayor de Cundinamarca, 2021
id UCOLMAYOR2_e4a9d10df993d9db6665fa86971ddb38
oai_identifier_str oai:repositorio.unicolmayor.edu.co:unicolmayor/2831
network_acronym_str UCOLMAYOR2
network_name_str Repositorio Colegio Mayor de Cundinamarca
repository_id_str
dc.title.spa.fl_str_mv Evaluación de la función efectora de Linfocitos T activados por péptidos provenientes de Mycobacterium Tuberculosis H37rv en Macrófagos Infectados por el Patógeno
title Evaluación de la función efectora de Linfocitos T activados por péptidos provenientes de Mycobacterium Tuberculosis H37rv en Macrófagos Infectados por el Patógeno
spellingShingle Evaluación de la función efectora de Linfocitos T activados por péptidos provenientes de Mycobacterium Tuberculosis H37rv en Macrófagos Infectados por el Patógeno
Linfocitos
Patógeno
Enfermedad
Salud pública
Tuberculosis
Mycobacterium tuberculosis H37Rv
Vacuna
Macrófagos
Péptidos sintéticos
Co-cultivo
Oxido nítrico
title_short Evaluación de la función efectora de Linfocitos T activados por péptidos provenientes de Mycobacterium Tuberculosis H37rv en Macrófagos Infectados por el Patógeno
title_full Evaluación de la función efectora de Linfocitos T activados por péptidos provenientes de Mycobacterium Tuberculosis H37rv en Macrófagos Infectados por el Patógeno
title_fullStr Evaluación de la función efectora de Linfocitos T activados por péptidos provenientes de Mycobacterium Tuberculosis H37rv en Macrófagos Infectados por el Patógeno
title_full_unstemmed Evaluación de la función efectora de Linfocitos T activados por péptidos provenientes de Mycobacterium Tuberculosis H37rv en Macrófagos Infectados por el Patógeno
title_sort Evaluación de la función efectora de Linfocitos T activados por péptidos provenientes de Mycobacterium Tuberculosis H37rv en Macrófagos Infectados por el Patógeno
dc.creator.fl_str_mv Vergara Vanegas, Valentina
dc.contributor.advisor.none.fl_str_mv Castro Molina, Susan Lorena
dc.contributor.author.none.fl_str_mv Vergara Vanegas, Valentina
dc.subject.lemb.none.fl_str_mv Linfocitos
Patógeno
Enfermedad
Salud pública
topic Linfocitos
Patógeno
Enfermedad
Salud pública
Tuberculosis
Mycobacterium tuberculosis H37Rv
Vacuna
Macrófagos
Péptidos sintéticos
Co-cultivo
Oxido nítrico
dc.subject.proposal.spa.fl_str_mv Tuberculosis
Mycobacterium tuberculosis H37Rv
Vacuna
Macrófagos
Péptidos sintéticos
Co-cultivo
Oxido nítrico
description La tuberculosis (TB) es una enfermedad infecto contagiosa, causada principalmente por Mycobacterium tuberculosis (Mtb), la cual sigue siendo una enfermedad de alto impacto en salud pública. Actualmente la única vacuna avalada por la OMS contra la TB, se fundamenta en un bacilo atenuado de Mycobacterium bovis BCG, con una eficacia variable que no confiere protección en adultos contra tuberculosis pulmonar. A pesar de la ardua investigación realizada por diferentes grupos en el mundo, los intentos de diseñar una vacuna eficaz contra la TB no han tenido éxito, ya que Mtb utiliza una variedad de mecanismos para prevenir su eliminación, no obstante, dada la problemática de la TB es necesario continuar con el desarrollo de las vacunas. En consecuencia, el presente trabajo pretende contribuir a la evaluación de antígenos propuestos por la FIDIC como posibles candidatos a vacuna contra la TB. Para ello, se escogieron 12 donantes a los cuales se les realizó pruebas diagnósticas de PPD y Quantiferon, adicionalmente, se genotipificó a cada donante los alelos DRβ1 del CMHII, para identificar la unión a péptidos derivados de proteínas de la superficie celular de Mtb H37Rv. A continuación, se obtuvieron linfocitos de los individuos, que se pulsaron con péptidos alelo específicos y producto de la interacción CMHII/TCR se produjo la linfoproliferación. Después, los linfocitos se pusieron en contacto con los macrófagos infectados con Mtb H37Rv (co-cultivo), con el fin de evaluar si la respuesta inducida por los péptidos era capaz de controlar el crecimiento del patógeno.
publishDate 2021
dc.date.accessioned.none.fl_str_mv 2021-09-09T18:58:45Z
dc.date.available.none.fl_str_mv 2021-09-09T18:58:45Z
dc.date.issued.none.fl_str_mv 2021-05-28
dc.type.spa.fl_str_mv Trabajo de grado - Pregrado
dc.type.coar.spa.fl_str_mv http://purl.org/coar/resource_type/c_7a1f
dc.type.coarversion.spa.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.content.spa.fl_str_mv Text
dc.type.driver.spa.fl_str_mv info:eu-repo/semantics/bachelorThesis
dc.type.redcol.spa.fl_str_mv https://purl.org/redcol/resource_type/TP
dc.type.version.spa.fl_str_mv info:eu-repo/semantics/publishedVersion
format http://purl.org/coar/resource_type/c_7a1f
status_str publishedVersion
dc.identifier.uri.none.fl_str_mv https://repositorio.unicolmayor.edu.co/handle/unicolmayor/2831
url https://repositorio.unicolmayor.edu.co/handle/unicolmayor/2831
dc.language.iso.spa.fl_str_mv spa
language spa
dc.relation.references.spa.fl_str_mv Organization WH. Global tuberculosis report 2020. 2020.
Mangtani P, Abubakar I, Ariti C, Beynon R, Pimpin L, et al. Protection by BCG Vaccine Against Tuberculosis: A Systematic Review of Randomized Controlled Trials. Clinical Infectious Diseases 2014; Volume 58, Pages 470– 480.
Worku S, Hoft DF. In vitro measurement of protective mycobacterial immunity: antigen-specific expansion of T cells capable of inhibiting intracellular growth of bacille Calmette-Guerin. Clinical infectious diseases. The Infectious Diseases Society of America 2000; 30 Suppl 3:S257-61.
Tanner R, O'Shea MK, Fletcher HA,McShane H. In vitro mycobacterial growth inhibition assays: A tool for the assessment of protective immunity and evaluation of tuberculosis vaccine efficacy. Vaccine 2016; Volume 34, Issue 39.
Sánchez-Barinas CD, Ocampo M, Tabares L,Bermúdez M, Patarroyo MA,Patarroyo ME. Specific Binding Peptides from Rv3632: A Strategy for Blocking Mycobacterium tuberculosis Entry to Target Cells?. BioMed Research International 2019.
Ocampo M Ramirez D, Rodríguez DM, Muñoz M, Curtidor H, et al. The role of Mycobacterium tuberculosis Rv3166c protein-derived high-activity binding peptides in inhibiting invasion of human cell lines Protein Engineering, Design and Selection 2012; Volume 25.
Moliva JI, Turner J, Torrelles JB. Prospects in Mycobacterium bovis Bacille Calmette et Guerin (BCG) vaccine diversity and delivery: why does BCG fail to protect against tuberculosis? Vaccine 2015; 33(39): 5035–5041.
Fletcher H, Tanner R, Wallis RS, Meyer J, Manjaly ZR, et al. Inhibition of mycobacterial growth in vitro following primary but not secondary vaccination with Mycobacterium bovis BCG. Clin Vaccine Immunol 2013; 20(11):1683-9.
Hoft DF, Worku S, Kampmann B, Whalen CC, Hirsch CS, et al. Investigation of the Relationships between Immune-Mediated Inhibition of Mycobacterial Growth and Other Potential Surrogate Markers of Protective Mycobacterium tuberculosis Immunity. The Journal of Infectious Diseases 2002; 186:1448– 57.
Carabali-Isajar ML, Ocampo M, Rodriguez DC, et al. Towards designing a synthetic antituberculosis vaccine: The Rv3587c peptide inhibits mycobacterial entry to host cells. Bioorganic & medicinal chemistry 2018; 26: 2401-9.
Kaufmann SH. How can immunology contribute to the control of tuberculosis?. Nature reviews Immunology 2001; 1: 20-30.
Bozzano F, Marras F, Maria AD. Immunology of tuberculosis. Mediterranean journal of hematology and infectious diseases 2014; 6: e2014027.
Martinez FO, Gordon S. The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep 2014; 6: 13.
Italiani P, B Boraschi D. From monocytes to M1/M2 macrophages: phenotypical vs. functional differentiation. Front Immunology 2014.
Parra M, Yang AL, Lim J, Kolibab K, Derrick S, Cadieux N, et al. Development of a murine mycobacterial growth inhibition assay for evaluating vaccines against Mycobacterium tuberculosis. Clinical and vaccine immunology, 2009; 16(7):1025-32.
McShane H, Williams A. A review of preclinical animal models utilised for TB vaccine evaluation in the context of recent human efficacy data. Tuberculosis. 2014; 94(2):105-10.
Mantilla Galindo A, Ocampo M, Patarroyo MA. Experimental models used in evaluating antituberculosis vaccines: the latest advances in the field. Expert Review of Vaccines 2019.
Yanti B, Mulyadi M, Amin M, Harapan H, Mertaniasih MN, et al. The role of Mycobacterium tuberculosis complex species on apoptosis and necroptosis state of macrophages derived from active pulmonary tuberculosis patients. BMC Research Notes 2020; Article number: 415.
Rath M, Müller I, Kropf P, Closs EI, Munder M. Metabolism via Arginase or Nitric Oxide Synthase: Two Competing Arginine Pathways in Macrophages. Front Immunol 2014; 5: 532.
Harirzadeh S, Kazemi MJ, Babakhani S. Identification of Mycobacterium tuberculosis isolated from culture-negative pulmonary and extra-pulmonary samples in cases of suspected tuberculosis. GMS Hyg Infect Control 2019; 14: Doc09.
O'Garra A, Redford PS, McNab FW, Bloom CI, et al. The Immune Response in Tuberculosis. Annu Rev Immunol, 2013; 31:475–527.
Kaufmann SH, Hussey G, Lambert PH. New vaccines for tuberculosis. Lancet 2010; 375(9731):2110-9.
Pai M, Berh M. Latent Mycobacterium tuberculosis Infection and Interferon- Gamma Release Assays. Microbiol Spectr 2016; 4(5).
Pai M, Denkinger CM, Kik SV, Rangaka MX, Zwerling A, et al. Gamma Interferon Release Assays for Detection of Mycobacterium tuberculosis Infection. Clin Microbiol Rev 2014; 27(1): 3–20.
Sekyere JO, Maphalala N, Malinga LA, Mbelle MN, Maningi NE. A Comparative Evaluation of the New Genexpert MTB/RIF Ultra and other Rapid Diagnostic Assays for Detecting Tuberculosis in Pulmonary and Extra Pulmonary Specimens. Scientific Reports 2019; 16587.
Baena A, Porcelli SA. Evasion and subversion of antigen presentation by Mycobacterium tuberculosis. Tissue Antigens 2010; 74(3): 189–204.
Ramakrishnan L. Revisiting the role of the granuloma in tuberculosis. Nat Rev Immunol 2012; 12(5):352-66.
Lambert C, Preijers F, Demirel GY, Sack U. Monocytes and macrophages in flow: an ESCCA initiative on advanced analyses of monocyte lineage using flow cytometry. International Clinical Cytometry Society 2015.
Deshmane SL,Kremlev S, Amini S, Sawaya BE. Monocyte Chemoattractant Protein-1 (MCP-1): An Overview. J Interferon Cytokine Res 2009; 29(6): 313– 326.
Nguyen L, Pieters J. The Trojan horse: survival tactics of pathogenic mycobacteria in macrophages. TRENDS in Cell Biology 2005; Vol.15 No.5.
Cipriani G, Gibbons SJ, Kashyap PC, Farrugia G. Intrinsic Gastrointestinal Macrophages: Their Phenotype and Role in Gastrointestinal Motility. Cellular and Molecular Gastroenterology and Hepatology 2016; 2.
Hammerbeck C, Goetz C, Newman K, Bonnevier J, Aggeler B. Phenotypic Characterization of Human M1 and M2a Macrophages Cultured with Different Serums and in the Presence or Absence of Polarizing Cytokines. R&D Systems 2018.
Kozloski GA. Macrophage Markers. MATER METHODS 2019; 9:2758.
Lalvani A, Millington KA. T Cells and Tuberculosis: Beyond Interferon-γ. The Journal of Infectious Diseases 2008; Volume 197, Pages 941–943.
Queval C, Song OR, Deboosère N, Delorme V, Debrie AS, et al. STAT3 Represses Nitric Oxide Synthesis in Human Macrophages upon Mycobacterium tuberculosis Infection. Scientific Reports 2016; 6:29297.
Jamaati H, Mortaz E, Pajouhi Z, Folkerts G, Movassaghi M, et al. Nitric Oxide in the Pathogenesis and Treatment of Tuberculosis. Front Microbiol 2017; 8: 2008.
Salvemini D; Doyle TM; Cuzzocrea S. Peroxynitrite and oxidative/nitrative stress in inflammation. Biochem Soc Trans 2006; 34 (5): 965–970.
Tripathi P, Kashyap L, Singh V. The role of nitric oxide in in£ammatory reactions. Immunology group, ICGEB 2007.
Romagnoli A, Etna MP, Giacomini E, Pardini M, Remoli ME, Corazzari M, et al. ESX-1 dependent impairment of autophagic flux by Mycobacterium tuberculosis in human dendritic cells. 2012; 8(9):1357-1370.
Tait DR., Hatherill M., Van Der Meeren O., Ginsberg AM., Van Brakel E., Salaun B., et al. Final Analysis of a Trial of M72/AS01E Vaccine to Prevent Tuberculosis. New England Journal of Medicine 2019.
Patarroyo ME, Patarroyo MA. Emerging rules for subunit-based, multiantigenic, multistage chemically synthesized vaccines. Acc Chem Res 2008; 41(3):377-86.
Ocampo M, Patarroyo MA, Vanegas M, Alba MP, Patarroyo ME. Functional, biochemical and 3D studies of Mycobacterium tuberculosis protein peptides for an effective anti-tuberculosis vaccine. Critical reviews in microbiology 2014; 40(2):117-45.
Ocampo M, Patarroyo MA, Vanegas M, Curtidor H, Patarroyo ME. Specific interaction between Mycobacterium tuberculosis lipoprotein-derived peptides and target cells inhibits mycobacterial entry in vitro. Chem Biol Drug Des 2014; 84(6): 626–641.
Rodrıguez D, Ocampo M, Varela Y, Curtidor H, Patarroyo MA,Patarroyo ME. Mce4F Mycobacterium tuberculosis protein peptides can inhibit invasion of human cell lines. FEMS Pathogens and Disease 2015; 73.
Sanchez-Barinas CD, Ocampo M, Vanegas M, Castaneda-Ramirez JJ, Patarroyo MA, Patarroyo ME. Mycobacterium tuberculosis H37Rv LpqG Protein Peptides Can Inhibit Mycobacterial Entry through Specific Interactions. Molecules 2018; 23 (3).
Rodríguez DC, Ocampo M, Reyes C, Arévalo-Pinzón G, Munoz M, et al. Peptide Specific Interaction Can Inhibit Mycobacterium tuberculosis H37Rv Infection. Journal of Cellular Biochemistry. Journal of Cellular Biochemistry 2016; 117:946–958.
Kumar K. Clinical implications of the global multidrug-resistant tuberculosis epidemic. Clin Med (Lond) 2016; 16(6): 565–570.
Organization PAH. Tuberculosis en las Américas 2019. 2019.
INS. Comportamiento de la Vigilancia de Tuberculosis, Colombia, semana 38 de 2020. 2020.
Delogu G, Sali M, Fadda G. The Biology of Mycobacterium Tuberculosis Infection. Mediterr J Hematol Infect Dis 2013; 5(1): e2013070.
Knight W & Gumbs L. Tuberculosis: An Overview. Primary Care: Clinics in Office Practice 2013; 40(3), 743–756.
Alderwick LJ, Harrison J, Lloyd GS, Birch HL. The Mycobacterial Cell Wall— Peptidoglycan and Arabinogalactan. Cold Spring Harb Perspect Med 2015; 5(8): a021113.
Kaur D, Guerin ME, Škovierová H, Brennan PJ y Jackson M. Biogenesis of the cell wall and other glycoconjugates of Mycobacterium tuberculosis. Adv Appl Microbiol 2011; 69: 23–78.
Cook GM, Berney M, Gebhard S, Heinemann M, Cox RA, et al. Physiology of Mycobacteria. Adv Microb Physiol 2013; 55: 81–319.
Li W, Deng G, Li M, Liu X, Wang Y. Roles of Mucosal Immunity against Mycobacterium tuberculosis Infection. Tuberc Res Treat 2012; 2012: 791728.
Churchyard G, Kim P, Shah SN, Rustomjee R, Gandhi N, et al. What We Know About Tuberculosis Transmission: An Overview. J Infect Dis 2017; 216(Suppl 6): S629.
Plüddemann A, Mukhopadhyay S & Gordon S. The interaction of macrophage receptors with bacterial ligands. Expert Reviews in Molecular Medicine, 2006; 8(28).
Zhai W, Wu F, Zhang Y, Fu Y, Liu Z. The Immune Escape Mechanisms of Mycobacterium Tuberculosis. International Journal of Molecular Sciences 2019.
59.Wieczorek M, Abualrous ET, Sticht J, Benito MA, Stolzenberg S, et al. Major Histocompatibility Complex (MHC) Class I and MHC Class II Proteins: Conformational Plasticity in Antigen Presentation. Front Immunol 2017; 8: 292.
Stern LJ, Calvo JM. HLA-DR: Molecular insights and vaccine design. Curr Pharm Des 2009; 15(28): 3249–3261.
Hubo M, Trinschek B, Kryczanowsky F, Tuettenberg A, Steinbrink K, Jonuleit H. Costimulatory molecules on immunogenic versus tolerogenic human dendritic cells. Front Immunology 2013; 3;4:82.
Martino M, Lodi L, Galli L, Chiappini E. Immune Response to Mycobacterium tuberculosis: A Narrative Review. Front Pediatr 2019.
Krishnan N, Robertson BD, Thwaites G. Pathways of IL-1β secretion by macrophages infected with clinical Mycobacterium tuberculosis strains. Tuberculosis (Edinb) 2013; 93(5): 538–547.
Davoust J, Banchereau J. Naked antigen-presenting molecules on dendritic cells. Nature Cell Biology 2000; E46–E48.
Santambrogio L, Sato A, Carven GJ, Belyanskaya SL, Strominger JL, et al. Extracellular antigen processing and presentation by immature dendritic cells. PNAS 1999; 15056-15061.
Manaury B. Proteases: Essential Actors in Processing Antigens and Intracellular Toll-Like Receptors. Front Immunol 2013; 4: 299.
Pires D, Marques J, Pombo JP, Carmo N, Bettencourt P, et al. Role of Cathepsins in Mycobacterium tuberculosis Survival in Human Macrophages. Sci Rep 2016; 10.1038 / srep32247.
Ehrt S, Schnappinger D. Mycobacterial survival strategies in the phagosome: Defense against host stresses. Cell Microbiol 2009; 11(8): 1170–1178.
Luiking YC, Engelen MP, Deutz NE. Regulation of Nitric oxide production in Health and Disease. Curr Opin Clin Nutr Metab Care 2011; 13(1): 97–104.
Flam BR, Eichler DC, Solomonson LP. Endothelial nitric oxide production is tightly coupled to the citrulline–NO cycle. Nitric Oxide 2007; 17(3-4), 115–121.
Durante W, Johnson FK, Johnson RA. Arginase: A critical Regulator of Nitric Oxide Synthesis ans Vascular Fuction. Clin Exp Pharmacol Physiol 2007; 34(9): 906–911.
Palmieri EM, McGinity C, Wink DA, McVicar DW. Nitric Oxide in Macrophage Immunometabolism: Hiding in Plain Sight. Metabolites 2020; 10(11): 429.
Bhat KH, Mukhopadhyay S. Macrophage takeover and the host–bacilli interplay during tuberculosis. Future Microbiology 2015; 10(5):853-872
Yang CY Yuk JM, Jo EK. The Role of Nitric Oxide in Mycobacterial Infections. Immune Netw 2009; 9(2): 46–52.
Geissmann F, Manz MG, Jung S, Sieweke MH, Merad M, et al. Development of monocytes, macrophages and dendritic cells. ScienceDirect 2010; 327(5966): 656–661.
Yang J, Zhang L, Yu C, Yang XF, Wang H. Monocyte and macrophage differentiation: circulation inflammatory monocyte as biomarker for inflammatory diseases. Biomark Res 2014; 2: 1.
Ruytinx P, Proost P, Damme JV, Struyf S. Chemokine-Induced Macrophage Polarization in Inflammatory Conditions. Front Immunol 2018; 9: 1930.
Ruytinx P, Proost P, Damme JV, Struyf S. Chemokine-Induced Macrophage Polarization in Inflammatory Conditions. Front Immunol 2018; 9: 1930.
Xu Y, Zhang M, Ramos CA, Durett A, Liu E, et al. Closely related T-memory stem cells correlate with in vivo expansion of CAR.CD19-T cells and are preserved by IL-7 and IL-15. Sangre 2014; 123 (24): 3750–3759.
Gattinoni L, Restifo N. Moving T memory stem cells to the clinic. INSIDE BLOOD 2013; 121 (4): 567–568.
Loddenkemper R, Lipman M, Zumla A. Clinical Aspects of Adult Tuberculosis. Cold Spring Harb Perspect Med 2016; 6(1): a017848.
Desikan P. Sputum smear microscopy in tuberculosis: Is it still relevant? Indian J Med Res 2013; 137(3): 442–444.
Lawn SD. Advances in Diagnostic Assays for Tuberculosis. Cold Spring Harb Perspect Med 2015; 5(12): a017806.
Azadi D, Motallebirad T, Ghaffari K, Shojaei H. Mycobacteriosis and Tuberculosis: Laboratory Diagnosis. Open Microbiol J 2018; 12: 41–58.
Campbell IA, Bah-Sow O. Pulmonary tuberculosis: diagnosis and treatment. BMJ 2006; 332(7551): 1194–1197.
Heemskerk D, Caws M, Marais B, Farrar J. Tuberculosis in Adults and Children. Diagnosis Springer 2015; Chapter 4.
Asmar S, Drancourt M. Rapid culture-based diagnosis of pulmonary tuberculosis in developed and developing countries. Front Microbiol 2015.
Palomino JC. Nonconventional and new methods in the diagnosis of tuberculosis: feasibility and applicability in the field. Eur Respir J 2005; 26: 339–350.
Khairunisa S. Herramientas de Diagnóstico de la Tuberculosis. Treatment Ation Group 2017.
Li J, Zhao A, Tanq J, Wanq G, Shi Y, et al. Tuberculosis vaccine development: from classic to clinical candidates. European Journal of Clinical Microbiology & Infectious Diseases 2020; 39, pages1405–1425.
Li Z, Zheng C, Terreni M, Tanzi L, et al. Novel Vaccine Candidates against Tuberculosis. Current Medicinal Chemistry, Bentham Science 2020; 27 (31), pp.5095 - 5118.
Houghten RA. General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids. Proc Natl Acad Sci U S A 1985; 82(15): 5131–5135.
Quah BJ, Warren HS, Parish CR. Monitoring lymphocyte proliferation in vitro and in vivo with the intracellular fluorescent dye carboxyfluorescein diacetate succinimidyl ester. Nat Protoc 2007; 2(9):2049-56.
Verdijk P, Veelen A, Ru H, Hensbergen PU, Mizuno K. Morphological changes during dendritic cell maturation correlate with cofilin activation and translocation to the cell membrane. Molecular immunity 2003; 34(1):156-64.
Toni LS, Garcia AM, Jeffrey DA, Jiang X, Stauffer BL, et al. Optimization of phenol-chloroform RNA extraction. ScienceDirect 2018; Volume 5, 2018, Pages 599-608.
Edgar RC. MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Research 2004; 32(5):1792-1797.
Zhang HJ, Yang R, Wang YT, Dong HW, Wang F, et al. A simple and practical method that prepares high molecular weight DNA ladders. Molecular Medicine Reports 2012; 1211-1213
Rodriguez D.C, Ocampo M, Salazar L.M, Patarroyo M.A. Quantifying intracellular Mycobacterium tuberculosis: An essential issue for in vitro assays. MicrobiologyOpen 2018; 7:e588
Bryan NS, Grisham MB. Methods to Detect Nitric Oxide and its Metabolites in Biological Samples. Free Radic Biol Med 2007; 43(5): 645–657.
Galarza F, Mc cabe A, Melo Dos Santos EJ, Jones J, Takeshita L, et al. Allele frequency net database (AFND) 2020 update: gold-standard data classification, open access genotype data and new query tools. Nucleic Acids Res 2020; 8;48(D1):D783-D788.
Reynisson B, Barra C, Kaabinejadian S, Hildebrand WH, Peters B, et al. Improved Prediction of MHC II Antigen Presentation through Integration and Motif Deconvolution of Mass Spectrometry MHC Eluted Ligand Data. J Proteome Res 2020; 19(6):2304-2315.
Mahamed D, Boulle M, Ganga Y, Mc Arthur C, Skroch S, et al. Intracellular growth of Mycobacterium tuberculosis after macrophage cell death leads to serial killing of host cells. Elife 2017; 28;6:e22028.
Curtidor H, Patarroyo M, Patarroyo MA. Recent advances in the development of a chemically synthesised anti-malarial vaccine. Expert Opin Biol Ther 2015; 40(2):117-45.
CarabaliI ML, Ocampo M, Varela Y, Arevalo D, Patarroyo MA, et al. Antibodies targeting Mycobacterium tuberculosis peptides inhibit mycobacterial entry to infection target cells. Biological Macromolecules 2020; Pages 712-720.
Lopez C, Yepes Y, Arevalo D, Patarroyo ME, Patarroyo MA. The in Vitro Antigenicity of Plasmodium vivax Rhoptry Neck Protein 2 (PvRON2) B- and T-Epitopes Selected by HLA-DRB1 Binding Profile. Front Cell Infect Microbiol 2018; 8: 156.
Howard M, Chesnut GR, Krieger J. Antigen Processing and Presentation by B Cells. The Molecular Basis of B-Cell Differentiation and Function 1986; pp 95-107.
Brinke A, Trzonkowska N, Mansilla MJ, Turksma AW, Piekarska K, et al. Monitoring T-Cell Responses in Translational Studies: Optimization of Dye-Based Proliferation Assay for Evaluation of Antigen-Specific Responses. Front Immunol 2017.
Kaufmann SH . Libro de Abbas Lancet 2010; 375:2110-19.
Yoon H, Kim TS, Braciale TJ. The Cell Cycle Time of CD8+ T Cells Responding In Vivo Is Controlled by the Type of Antigenic Stimulus. PLoS One 2010; 5(11): e15423.
Yang H, Garcia N, Dobos KM. Purified protein derivatives of tuberculin- -past, present, and future. FEMS Immunol Med Microbiol 2012; Dec;66(3):273-80.
Urdahl KB, Shafiani S, Ernst JD. Initiation and regulation of T-cell responses in tuberculosis. Mucosal Immunology 2011; 4, pages288–293.
Achkar JM, Chan J, Casadevall A. B cells and antibodies in the defense against Mycobacterium tuberculosis infection. Immunological Reviews 2015; 264 , Número 1.
dc.rights.spa.fl_str_mv Derechos Reservados - Universidad Colegio Mayor de Cundinamarca, 2021
dc.rights.uri.spa.fl_str_mv https://creativecommons.org/licenses/by-nc-sa/4.0/
dc.rights.accessrights.spa.fl_str_mv info:eu-repo/semantics/closedAccess
dc.rights.creativecommons.spa.fl_str_mv Atribución-NoComercial-CompartirIgual 4.0 Internacional (CC BY-NC-SA 4.0)
dc.rights.coar.spa.fl_str_mv http://purl.org/coar/access_right/c_14cb
rights_invalid_str_mv Derechos Reservados - Universidad Colegio Mayor de Cundinamarca, 2021
https://creativecommons.org/licenses/by-nc-sa/4.0/
Atribución-NoComercial-CompartirIgual 4.0 Internacional (CC BY-NC-SA 4.0)
http://purl.org/coar/access_right/c_14cb
eu_rights_str_mv closedAccess
dc.format.extent.spa.fl_str_mv 108p.
dc.format.mimetype.spa.fl_str_mv application/pdf
dc.publisher.spa.fl_str_mv Universidad Colegio Mayor de Cundinamarca
dc.publisher.faculty.spa.fl_str_mv Facultad de Ciencias de la Salud
dc.publisher.place.spa.fl_str_mv Bogotá D.C
dc.publisher.program.spa.fl_str_mv Bacteriología y Laboratorio Clínico
institution Colegio Mayor de Cundinamarca
bitstream.url.fl_str_mv https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/2831/1/firmadaDERECHOS%20DE%20AUTOR%20TG%202021ValentinaVergara.pdf
https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/2831/2/Valentina%20Vergara%20Vanegas%20Presentaci%c3%b3n%20Tesis%20de%20grado%20final%20pdf.pdf
https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/2831/3/Formato%20decanatura%202.pdf
https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/2831/4/Valentina%20Vergara%20Vanegas%20Trabajo%20DE%20GRADO%20TBC%20FINAL.pdf
https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/2831/5/license.txt
https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/2831/6/firmadaDERECHOS%20DE%20AUTOR%20TG%202021ValentinaVergara.pdf.txt
https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/2831/8/Valentina%20Vergara%20Vanegas%20Presentaci%c3%b3n%20Tesis%20de%20grado%20final%20pdf.pdf.txt
https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/2831/10/Formato%20decanatura%202.pdf.txt
https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/2831/7/firmadaDERECHOS%20DE%20AUTOR%20TG%202021ValentinaVergara.pdf.jpg
https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/2831/9/Valentina%20Vergara%20Vanegas%20Presentaci%c3%b3n%20Tesis%20de%20grado%20final%20pdf.pdf.jpg
https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/2831/11/Formato%20decanatura%202.pdf.jpg
bitstream.checksum.fl_str_mv e2f2ec6f9c3867a816dd3df0fa804870
96eb9d5fb2518c2de0dc9ba4974be60a
47a10dd5bcdbc1dc0389e9a594d751ac
b985a9d612689d0f6cbe3da1b5b04e5b
2f9959eaf5b71fae44bbf9ec84150c7a
6a3846559aaaad30aff5d828aaab83a8
334e0ee1367f1665d1da3a52ea13cdb5
68b329da9893e34099c7d8ad5cb9c940
2d11c3e58ca224da3e58ab50a4636d09
bb05eddbccc745988b4686c38588e1b6
f957706ed46e826f36a21449284c68be
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
MD5
MD5
MD5
MD5
MD5
MD5
MD5
repository.name.fl_str_mv Biblioteca Digital Unicolmayor
repository.mail.fl_str_mv repositorio@unicolmayor.edu.co
_version_ 1812210081542963200
spelling Castro Molina, Susan Lorena0538d7d5bb55e1323777cf3c55bf6d1a600Vergara Vanegas, Valentina2dee845a6d1c0a325cd8c3b08473b7b86002021-09-09T18:58:45Z2021-09-09T18:58:45Z2021-05-28https://repositorio.unicolmayor.edu.co/handle/unicolmayor/2831La tuberculosis (TB) es una enfermedad infecto contagiosa, causada principalmente por Mycobacterium tuberculosis (Mtb), la cual sigue siendo una enfermedad de alto impacto en salud pública. Actualmente la única vacuna avalada por la OMS contra la TB, se fundamenta en un bacilo atenuado de Mycobacterium bovis BCG, con una eficacia variable que no confiere protección en adultos contra tuberculosis pulmonar. A pesar de la ardua investigación realizada por diferentes grupos en el mundo, los intentos de diseñar una vacuna eficaz contra la TB no han tenido éxito, ya que Mtb utiliza una variedad de mecanismos para prevenir su eliminación, no obstante, dada la problemática de la TB es necesario continuar con el desarrollo de las vacunas. En consecuencia, el presente trabajo pretende contribuir a la evaluación de antígenos propuestos por la FIDIC como posibles candidatos a vacuna contra la TB. Para ello, se escogieron 12 donantes a los cuales se les realizó pruebas diagnósticas de PPD y Quantiferon, adicionalmente, se genotipificó a cada donante los alelos DRβ1 del CMHII, para identificar la unión a péptidos derivados de proteínas de la superficie celular de Mtb H37Rv. A continuación, se obtuvieron linfocitos de los individuos, que se pulsaron con péptidos alelo específicos y producto de la interacción CMHII/TCR se produjo la linfoproliferación. Después, los linfocitos se pusieron en contacto con los macrófagos infectados con Mtb H37Rv (co-cultivo), con el fin de evaluar si la respuesta inducida por los péptidos era capaz de controlar el crecimiento del patógeno.RESUMEN INTRODUCCIÓN 13 1. PREGUNTA PROBLEMA 15 2. JUSTIFICACIÓN 17 3. ANTECEDENTES 19 4. OBJETIVOS 25 4.1 Objetivo General 25 4.2 Objetivos Específicos 25 5. MARCO TEÓRICO 26 5.1 Epidemiología de la TB 26 5.2 Generalidades de Mycobacterium tuberculosis 28 5.3 Respuesta inmune contra tuberculosis 29 5.4 Procesamiento antigénico por parte de macrófagos 34 5.5 Métodos in vitro para la obtención de macrófagos 37 5.6 Memoria Inmunológica en las celulas T 38 5.7 Pruebas Diagnósticas 39 5.8 Modelos Vacunales 44 6 DISEÑO METODOLÓGICO 46 6.1 Universo, población, muestra 46 6.2 Hipótesis, variables, indicadores 46 6.3 Variables 46 6.4 Técnicas y procedimientos. 47 6.4.1 Grupo de estudio 47 6.4.2 Selección de péptidos sintéticos 47 6.4.3 Ensayo de Linfoproliferación 49 6.4.4 Determinación memoria inmunológica 50 6.4.5 Obtención de monocitos para derivar a macrófagos 51 6.4.5.1 Obtención de PMBCs y macrófagos 51 6.4.5.2 Zimografía- Activación del macrófago por liberación de proteasas 52 6.4.5.3 Identificación de IL-10 y IL-12 para la activación del macrófago 53 6.4.6 Mantenimiento de Mtb H37Rv 56 6.4.7 Fagocitosis de Mtb H37Rv en macrófagos 56 6.4.8 Co-cultivo de linfocitos T estimulados con macrófagos infectados con Mtb 56 6.4.9 Evaluación del crecimiento intracelular de Mtb H37Rv 57 6.4.10 Medición de Óxido nítrico 57 7. RESULTADOS 58 7.1 Selección del grupo de estudio y unión al CMH-ll 58 7.2 Ensayo de linfoproliferación 61 7.3 Evaluación de memoria inmunológica 67 7.4 Diferenciación de monocitos a macrófagos 69 7.5 Mantenimiento y crecimiento de Mtb H37Rv 74 7.6 Estandarización del MOI de infección en macrófagos 75 7.7 Ensayo de co-cultivo 75 7.8 Cuantificación y evaluación de la producción del óxido nítrico 78 8 DISCUSIÓN DE RESULTADOS 81 9 CONCLUSIONES 88 10. REFERENCIAS BIBLIOGRÁFICAS 91PregradoBacteriólogo(a) y Laboratorista Clínico108p.application/pdfspaUniversidad Colegio Mayor de CundinamarcaFacultad de Ciencias de la SaludBogotá D.CBacteriología y Laboratorio ClínicoDerechos Reservados - Universidad Colegio Mayor de Cundinamarca, 2021https://creativecommons.org/licenses/by-nc-sa/4.0/info:eu-repo/semantics/closedAccessAtribución-NoComercial-CompartirIgual 4.0 Internacional (CC BY-NC-SA 4.0)http://purl.org/coar/access_right/c_14cbEvaluación de la función efectora de Linfocitos T activados por péptidos provenientes de Mycobacterium Tuberculosis H37rv en Macrófagos Infectados por el PatógenoTrabajo de grado - Pregradohttp://purl.org/coar/resource_type/c_7a1fhttp://purl.org/coar/version/c_970fb48d4fbd8a85Textinfo:eu-repo/semantics/bachelorThesishttps://purl.org/redcol/resource_type/TPinfo:eu-repo/semantics/publishedVersionOrganization WH. Global tuberculosis report 2020. 2020.Mangtani P, Abubakar I, Ariti C, Beynon R, Pimpin L, et al. Protection by BCG Vaccine Against Tuberculosis: A Systematic Review of Randomized Controlled Trials. Clinical Infectious Diseases 2014; Volume 58, Pages 470– 480.Worku S, Hoft DF. In vitro measurement of protective mycobacterial immunity: antigen-specific expansion of T cells capable of inhibiting intracellular growth of bacille Calmette-Guerin. Clinical infectious diseases. The Infectious Diseases Society of America 2000; 30 Suppl 3:S257-61.Tanner R, O'Shea MK, Fletcher HA,McShane H. In vitro mycobacterial growth inhibition assays: A tool for the assessment of protective immunity and evaluation of tuberculosis vaccine efficacy. Vaccine 2016; Volume 34, Issue 39.Sánchez-Barinas CD, Ocampo M, Tabares L,Bermúdez M, Patarroyo MA,Patarroyo ME. Specific Binding Peptides from Rv3632: A Strategy for Blocking Mycobacterium tuberculosis Entry to Target Cells?. BioMed Research International 2019.Ocampo M Ramirez D, Rodríguez DM, Muñoz M, Curtidor H, et al. The role of Mycobacterium tuberculosis Rv3166c protein-derived high-activity binding peptides in inhibiting invasion of human cell lines Protein Engineering, Design and Selection 2012; Volume 25.Moliva JI, Turner J, Torrelles JB. Prospects in Mycobacterium bovis Bacille Calmette et Guerin (BCG) vaccine diversity and delivery: why does BCG fail to protect against tuberculosis? Vaccine 2015; 33(39): 5035–5041.Fletcher H, Tanner R, Wallis RS, Meyer J, Manjaly ZR, et al. Inhibition of mycobacterial growth in vitro following primary but not secondary vaccination with Mycobacterium bovis BCG. Clin Vaccine Immunol 2013; 20(11):1683-9.Hoft DF, Worku S, Kampmann B, Whalen CC, Hirsch CS, et al. Investigation of the Relationships between Immune-Mediated Inhibition of Mycobacterial Growth and Other Potential Surrogate Markers of Protective Mycobacterium tuberculosis Immunity. The Journal of Infectious Diseases 2002; 186:1448– 57.Carabali-Isajar ML, Ocampo M, Rodriguez DC, et al. Towards designing a synthetic antituberculosis vaccine: The Rv3587c peptide inhibits mycobacterial entry to host cells. Bioorganic & medicinal chemistry 2018; 26: 2401-9.Kaufmann SH. How can immunology contribute to the control of tuberculosis?. Nature reviews Immunology 2001; 1: 20-30.Bozzano F, Marras F, Maria AD. Immunology of tuberculosis. Mediterranean journal of hematology and infectious diseases 2014; 6: e2014027.Martinez FO, Gordon S. The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep 2014; 6: 13.Italiani P, B Boraschi D. From monocytes to M1/M2 macrophages: phenotypical vs. functional differentiation. Front Immunology 2014.Parra M, Yang AL, Lim J, Kolibab K, Derrick S, Cadieux N, et al. Development of a murine mycobacterial growth inhibition assay for evaluating vaccines against Mycobacterium tuberculosis. Clinical and vaccine immunology, 2009; 16(7):1025-32.McShane H, Williams A. A review of preclinical animal models utilised for TB vaccine evaluation in the context of recent human efficacy data. Tuberculosis. 2014; 94(2):105-10.Mantilla Galindo A, Ocampo M, Patarroyo MA. Experimental models used in evaluating antituberculosis vaccines: the latest advances in the field. Expert Review of Vaccines 2019.Yanti B, Mulyadi M, Amin M, Harapan H, Mertaniasih MN, et al. The role of Mycobacterium tuberculosis complex species on apoptosis and necroptosis state of macrophages derived from active pulmonary tuberculosis patients. BMC Research Notes 2020; Article number: 415.Rath M, Müller I, Kropf P, Closs EI, Munder M. Metabolism via Arginase or Nitric Oxide Synthase: Two Competing Arginine Pathways in Macrophages. Front Immunol 2014; 5: 532.Harirzadeh S, Kazemi MJ, Babakhani S. Identification of Mycobacterium tuberculosis isolated from culture-negative pulmonary and extra-pulmonary samples in cases of suspected tuberculosis. GMS Hyg Infect Control 2019; 14: Doc09.O'Garra A, Redford PS, McNab FW, Bloom CI, et al. The Immune Response in Tuberculosis. Annu Rev Immunol, 2013; 31:475–527.Kaufmann SH, Hussey G, Lambert PH. New vaccines for tuberculosis. Lancet 2010; 375(9731):2110-9.Pai M, Berh M. Latent Mycobacterium tuberculosis Infection and Interferon- Gamma Release Assays. Microbiol Spectr 2016; 4(5).Pai M, Denkinger CM, Kik SV, Rangaka MX, Zwerling A, et al. Gamma Interferon Release Assays for Detection of Mycobacterium tuberculosis Infection. Clin Microbiol Rev 2014; 27(1): 3–20.Sekyere JO, Maphalala N, Malinga LA, Mbelle MN, Maningi NE. A Comparative Evaluation of the New Genexpert MTB/RIF Ultra and other Rapid Diagnostic Assays for Detecting Tuberculosis in Pulmonary and Extra Pulmonary Specimens. Scientific Reports 2019; 16587.Baena A, Porcelli SA. Evasion and subversion of antigen presentation by Mycobacterium tuberculosis. Tissue Antigens 2010; 74(3): 189–204.Ramakrishnan L. Revisiting the role of the granuloma in tuberculosis. Nat Rev Immunol 2012; 12(5):352-66.Lambert C, Preijers F, Demirel GY, Sack U. Monocytes and macrophages in flow: an ESCCA initiative on advanced analyses of monocyte lineage using flow cytometry. International Clinical Cytometry Society 2015.Deshmane SL,Kremlev S, Amini S, Sawaya BE. Monocyte Chemoattractant Protein-1 (MCP-1): An Overview. J Interferon Cytokine Res 2009; 29(6): 313– 326.Nguyen L, Pieters J. The Trojan horse: survival tactics of pathogenic mycobacteria in macrophages. TRENDS in Cell Biology 2005; Vol.15 No.5.Cipriani G, Gibbons SJ, Kashyap PC, Farrugia G. Intrinsic Gastrointestinal Macrophages: Their Phenotype and Role in Gastrointestinal Motility. Cellular and Molecular Gastroenterology and Hepatology 2016; 2.Hammerbeck C, Goetz C, Newman K, Bonnevier J, Aggeler B. Phenotypic Characterization of Human M1 and M2a Macrophages Cultured with Different Serums and in the Presence or Absence of Polarizing Cytokines. R&D Systems 2018.Kozloski GA. Macrophage Markers. MATER METHODS 2019; 9:2758.Lalvani A, Millington KA. T Cells and Tuberculosis: Beyond Interferon-γ. The Journal of Infectious Diseases 2008; Volume 197, Pages 941–943.Queval C, Song OR, Deboosère N, Delorme V, Debrie AS, et al. STAT3 Represses Nitric Oxide Synthesis in Human Macrophages upon Mycobacterium tuberculosis Infection. Scientific Reports 2016; 6:29297.Jamaati H, Mortaz E, Pajouhi Z, Folkerts G, Movassaghi M, et al. Nitric Oxide in the Pathogenesis and Treatment of Tuberculosis. Front Microbiol 2017; 8: 2008.Salvemini D; Doyle TM; Cuzzocrea S. Peroxynitrite and oxidative/nitrative stress in inflammation. Biochem Soc Trans 2006; 34 (5): 965–970.Tripathi P, Kashyap L, Singh V. The role of nitric oxide in in£ammatory reactions. Immunology group, ICGEB 2007.Romagnoli A, Etna MP, Giacomini E, Pardini M, Remoli ME, Corazzari M, et al. ESX-1 dependent impairment of autophagic flux by Mycobacterium tuberculosis in human dendritic cells. 2012; 8(9):1357-1370.Tait DR., Hatherill M., Van Der Meeren O., Ginsberg AM., Van Brakel E., Salaun B., et al. Final Analysis of a Trial of M72/AS01E Vaccine to Prevent Tuberculosis. New England Journal of Medicine 2019.Patarroyo ME, Patarroyo MA. Emerging rules for subunit-based, multiantigenic, multistage chemically synthesized vaccines. Acc Chem Res 2008; 41(3):377-86.Ocampo M, Patarroyo MA, Vanegas M, Alba MP, Patarroyo ME. Functional, biochemical and 3D studies of Mycobacterium tuberculosis protein peptides for an effective anti-tuberculosis vaccine. Critical reviews in microbiology 2014; 40(2):117-45.Ocampo M, Patarroyo MA, Vanegas M, Curtidor H, Patarroyo ME. Specific interaction between Mycobacterium tuberculosis lipoprotein-derived peptides and target cells inhibits mycobacterial entry in vitro. Chem Biol Drug Des 2014; 84(6): 626–641.Rodrıguez D, Ocampo M, Varela Y, Curtidor H, Patarroyo MA,Patarroyo ME. Mce4F Mycobacterium tuberculosis protein peptides can inhibit invasion of human cell lines. FEMS Pathogens and Disease 2015; 73.Sanchez-Barinas CD, Ocampo M, Vanegas M, Castaneda-Ramirez JJ, Patarroyo MA, Patarroyo ME. Mycobacterium tuberculosis H37Rv LpqG Protein Peptides Can Inhibit Mycobacterial Entry through Specific Interactions. Molecules 2018; 23 (3).Rodríguez DC, Ocampo M, Reyes C, Arévalo-Pinzón G, Munoz M, et al. Peptide Specific Interaction Can Inhibit Mycobacterium tuberculosis H37Rv Infection. Journal of Cellular Biochemistry. Journal of Cellular Biochemistry 2016; 117:946–958.Kumar K. Clinical implications of the global multidrug-resistant tuberculosis epidemic. Clin Med (Lond) 2016; 16(6): 565–570.Organization PAH. Tuberculosis en las Américas 2019. 2019.INS. Comportamiento de la Vigilancia de Tuberculosis, Colombia, semana 38 de 2020. 2020.Delogu G, Sali M, Fadda G. The Biology of Mycobacterium Tuberculosis Infection. Mediterr J Hematol Infect Dis 2013; 5(1): e2013070.Knight W & Gumbs L. Tuberculosis: An Overview. Primary Care: Clinics in Office Practice 2013; 40(3), 743–756.Alderwick LJ, Harrison J, Lloyd GS, Birch HL. The Mycobacterial Cell Wall— Peptidoglycan and Arabinogalactan. Cold Spring Harb Perspect Med 2015; 5(8): a021113.Kaur D, Guerin ME, Škovierová H, Brennan PJ y Jackson M. Biogenesis of the cell wall and other glycoconjugates of Mycobacterium tuberculosis. Adv Appl Microbiol 2011; 69: 23–78.Cook GM, Berney M, Gebhard S, Heinemann M, Cox RA, et al. Physiology of Mycobacteria. Adv Microb Physiol 2013; 55: 81–319.Li W, Deng G, Li M, Liu X, Wang Y. Roles of Mucosal Immunity against Mycobacterium tuberculosis Infection. Tuberc Res Treat 2012; 2012: 791728.Churchyard G, Kim P, Shah SN, Rustomjee R, Gandhi N, et al. What We Know About Tuberculosis Transmission: An Overview. J Infect Dis 2017; 216(Suppl 6): S629.Plüddemann A, Mukhopadhyay S & Gordon S. The interaction of macrophage receptors with bacterial ligands. Expert Reviews in Molecular Medicine, 2006; 8(28).Zhai W, Wu F, Zhang Y, Fu Y, Liu Z. The Immune Escape Mechanisms of Mycobacterium Tuberculosis. International Journal of Molecular Sciences 2019.59.Wieczorek M, Abualrous ET, Sticht J, Benito MA, Stolzenberg S, et al. Major Histocompatibility Complex (MHC) Class I and MHC Class II Proteins: Conformational Plasticity in Antigen Presentation. Front Immunol 2017; 8: 292.Stern LJ, Calvo JM. HLA-DR: Molecular insights and vaccine design. Curr Pharm Des 2009; 15(28): 3249–3261.Hubo M, Trinschek B, Kryczanowsky F, Tuettenberg A, Steinbrink K, Jonuleit H. Costimulatory molecules on immunogenic versus tolerogenic human dendritic cells. Front Immunology 2013; 3;4:82.Martino M, Lodi L, Galli L, Chiappini E. Immune Response to Mycobacterium tuberculosis: A Narrative Review. Front Pediatr 2019.Krishnan N, Robertson BD, Thwaites G. Pathways of IL-1β secretion by macrophages infected with clinical Mycobacterium tuberculosis strains. Tuberculosis (Edinb) 2013; 93(5): 538–547.Davoust J, Banchereau J. Naked antigen-presenting molecules on dendritic cells. Nature Cell Biology 2000; E46–E48.Santambrogio L, Sato A, Carven GJ, Belyanskaya SL, Strominger JL, et al. Extracellular antigen processing and presentation by immature dendritic cells. PNAS 1999; 15056-15061.Manaury B. Proteases: Essential Actors in Processing Antigens and Intracellular Toll-Like Receptors. Front Immunol 2013; 4: 299.Pires D, Marques J, Pombo JP, Carmo N, Bettencourt P, et al. Role of Cathepsins in Mycobacterium tuberculosis Survival in Human Macrophages. Sci Rep 2016; 10.1038 / srep32247.Ehrt S, Schnappinger D. Mycobacterial survival strategies in the phagosome: Defense against host stresses. Cell Microbiol 2009; 11(8): 1170–1178.Luiking YC, Engelen MP, Deutz NE. Regulation of Nitric oxide production in Health and Disease. Curr Opin Clin Nutr Metab Care 2011; 13(1): 97–104.Flam BR, Eichler DC, Solomonson LP. Endothelial nitric oxide production is tightly coupled to the citrulline–NO cycle. Nitric Oxide 2007; 17(3-4), 115–121.Durante W, Johnson FK, Johnson RA. Arginase: A critical Regulator of Nitric Oxide Synthesis ans Vascular Fuction. Clin Exp Pharmacol Physiol 2007; 34(9): 906–911.Palmieri EM, McGinity C, Wink DA, McVicar DW. Nitric Oxide in Macrophage Immunometabolism: Hiding in Plain Sight. Metabolites 2020; 10(11): 429.Bhat KH, Mukhopadhyay S. Macrophage takeover and the host–bacilli interplay during tuberculosis. Future Microbiology 2015; 10(5):853-872Yang CY Yuk JM, Jo EK. The Role of Nitric Oxide in Mycobacterial Infections. Immune Netw 2009; 9(2): 46–52.Geissmann F, Manz MG, Jung S, Sieweke MH, Merad M, et al. Development of monocytes, macrophages and dendritic cells. ScienceDirect 2010; 327(5966): 656–661.Yang J, Zhang L, Yu C, Yang XF, Wang H. Monocyte and macrophage differentiation: circulation inflammatory monocyte as biomarker for inflammatory diseases. Biomark Res 2014; 2: 1.Ruytinx P, Proost P, Damme JV, Struyf S. Chemokine-Induced Macrophage Polarization in Inflammatory Conditions. Front Immunol 2018; 9: 1930.Ruytinx P, Proost P, Damme JV, Struyf S. Chemokine-Induced Macrophage Polarization in Inflammatory Conditions. Front Immunol 2018; 9: 1930.Xu Y, Zhang M, Ramos CA, Durett A, Liu E, et al. Closely related T-memory stem cells correlate with in vivo expansion of CAR.CD19-T cells and are preserved by IL-7 and IL-15. Sangre 2014; 123 (24): 3750–3759.Gattinoni L, Restifo N. Moving T memory stem cells to the clinic. INSIDE BLOOD 2013; 121 (4): 567–568.Loddenkemper R, Lipman M, Zumla A. Clinical Aspects of Adult Tuberculosis. Cold Spring Harb Perspect Med 2016; 6(1): a017848.Desikan P. Sputum smear microscopy in tuberculosis: Is it still relevant? Indian J Med Res 2013; 137(3): 442–444.Lawn SD. Advances in Diagnostic Assays for Tuberculosis. Cold Spring Harb Perspect Med 2015; 5(12): a017806.Azadi D, Motallebirad T, Ghaffari K, Shojaei H. Mycobacteriosis and Tuberculosis: Laboratory Diagnosis. Open Microbiol J 2018; 12: 41–58.Campbell IA, Bah-Sow O. Pulmonary tuberculosis: diagnosis and treatment. BMJ 2006; 332(7551): 1194–1197.Heemskerk D, Caws M, Marais B, Farrar J. Tuberculosis in Adults and Children. Diagnosis Springer 2015; Chapter 4.Asmar S, Drancourt M. Rapid culture-based diagnosis of pulmonary tuberculosis in developed and developing countries. Front Microbiol 2015.Palomino JC. Nonconventional and new methods in the diagnosis of tuberculosis: feasibility and applicability in the field. Eur Respir J 2005; 26: 339–350.Khairunisa S. Herramientas de Diagnóstico de la Tuberculosis. Treatment Ation Group 2017.Li J, Zhao A, Tanq J, Wanq G, Shi Y, et al. Tuberculosis vaccine development: from classic to clinical candidates. European Journal of Clinical Microbiology & Infectious Diseases 2020; 39, pages1405–1425.Li Z, Zheng C, Terreni M, Tanzi L, et al. Novel Vaccine Candidates against Tuberculosis. Current Medicinal Chemistry, Bentham Science 2020; 27 (31), pp.5095 - 5118.Houghten RA. General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids. Proc Natl Acad Sci U S A 1985; 82(15): 5131–5135.Quah BJ, Warren HS, Parish CR. Monitoring lymphocyte proliferation in vitro and in vivo with the intracellular fluorescent dye carboxyfluorescein diacetate succinimidyl ester. Nat Protoc 2007; 2(9):2049-56.Verdijk P, Veelen A, Ru H, Hensbergen PU, Mizuno K. Morphological changes during dendritic cell maturation correlate with cofilin activation and translocation to the cell membrane. Molecular immunity 2003; 34(1):156-64.Toni LS, Garcia AM, Jeffrey DA, Jiang X, Stauffer BL, et al. Optimization of phenol-chloroform RNA extraction. ScienceDirect 2018; Volume 5, 2018, Pages 599-608.Edgar RC. MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Research 2004; 32(5):1792-1797.Zhang HJ, Yang R, Wang YT, Dong HW, Wang F, et al. A simple and practical method that prepares high molecular weight DNA ladders. Molecular Medicine Reports 2012; 1211-1213Rodriguez D.C, Ocampo M, Salazar L.M, Patarroyo M.A. Quantifying intracellular Mycobacterium tuberculosis: An essential issue for in vitro assays. MicrobiologyOpen 2018; 7:e588Bryan NS, Grisham MB. Methods to Detect Nitric Oxide and its Metabolites in Biological Samples. Free Radic Biol Med 2007; 43(5): 645–657.Galarza F, Mc cabe A, Melo Dos Santos EJ, Jones J, Takeshita L, et al. Allele frequency net database (AFND) 2020 update: gold-standard data classification, open access genotype data and new query tools. Nucleic Acids Res 2020; 8;48(D1):D783-D788.Reynisson B, Barra C, Kaabinejadian S, Hildebrand WH, Peters B, et al. Improved Prediction of MHC II Antigen Presentation through Integration and Motif Deconvolution of Mass Spectrometry MHC Eluted Ligand Data. J Proteome Res 2020; 19(6):2304-2315.Mahamed D, Boulle M, Ganga Y, Mc Arthur C, Skroch S, et al. Intracellular growth of Mycobacterium tuberculosis after macrophage cell death leads to serial killing of host cells. Elife 2017; 28;6:e22028.Curtidor H, Patarroyo M, Patarroyo MA. Recent advances in the development of a chemically synthesised anti-malarial vaccine. Expert Opin Biol Ther 2015; 40(2):117-45.CarabaliI ML, Ocampo M, Varela Y, Arevalo D, Patarroyo MA, et al. Antibodies targeting Mycobacterium tuberculosis peptides inhibit mycobacterial entry to infection target cells. Biological Macromolecules 2020; Pages 712-720.Lopez C, Yepes Y, Arevalo D, Patarroyo ME, Patarroyo MA. The in Vitro Antigenicity of Plasmodium vivax Rhoptry Neck Protein 2 (PvRON2) B- and T-Epitopes Selected by HLA-DRB1 Binding Profile. Front Cell Infect Microbiol 2018; 8: 156.Howard M, Chesnut GR, Krieger J. Antigen Processing and Presentation by B Cells. The Molecular Basis of B-Cell Differentiation and Function 1986; pp 95-107.Brinke A, Trzonkowska N, Mansilla MJ, Turksma AW, Piekarska K, et al. Monitoring T-Cell Responses in Translational Studies: Optimization of Dye-Based Proliferation Assay for Evaluation of Antigen-Specific Responses. Front Immunol 2017.Kaufmann SH . Libro de Abbas Lancet 2010; 375:2110-19.Yoon H, Kim TS, Braciale TJ. The Cell Cycle Time of CD8+ T Cells Responding In Vivo Is Controlled by the Type of Antigenic Stimulus. PLoS One 2010; 5(11): e15423.Yang H, Garcia N, Dobos KM. Purified protein derivatives of tuberculin- -past, present, and future. FEMS Immunol Med Microbiol 2012; Dec;66(3):273-80.Urdahl KB, Shafiani S, Ernst JD. Initiation and regulation of T-cell responses in tuberculosis. Mucosal Immunology 2011; 4, pages288–293.Achkar JM, Chan J, Casadevall A. B cells and antibodies in the defense against Mycobacterium tuberculosis infection. Immunological Reviews 2015; 264 , Número 1.LinfocitosPatógenoEnfermedadSalud públicaTuberculosisMycobacterium tuberculosis H37RvVacunaMacrófagosPéptidos sintéticosCo-cultivoOxido nítricoORIGINALfirmadaDERECHOS DE AUTOR TG 2021ValentinaVergara.pdffirmadaDERECHOS DE AUTOR TG 2021ValentinaVergara.pdfapplication/pdf440938https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/2831/1/firmadaDERECHOS%20DE%20AUTOR%20TG%202021ValentinaVergara.pdfe2f2ec6f9c3867a816dd3df0fa804870MD51metadata only accessValentina Vergara Vanegas Presentación Tesis de grado final pdf.pdfValentina Vergara Vanegas Presentación Tesis de grado final pdf.pdfapplication/pdf3650535https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/2831/2/Valentina%20Vergara%20Vanegas%20Presentaci%c3%b3n%20Tesis%20de%20grado%20final%20pdf.pdf96eb9d5fb2518c2de0dc9ba4974be60aMD52open accessFormato decanatura 2.pdfFormato decanatura 2.pdfapplication/pdf80639https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/2831/3/Formato%20decanatura%202.pdf47a10dd5bcdbc1dc0389e9a594d751acMD53metadata only accessValentina Vergara Vanegas Trabajo DE GRADO TBC FINAL.pdfValentina Vergara Vanegas Trabajo DE GRADO TBC FINAL.pdfapplication/pdf9437184https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/2831/4/Valentina%20Vergara%20Vanegas%20Trabajo%20DE%20GRADO%20TBC%20FINAL.pdfb985a9d612689d0f6cbe3da1b5b04e5bMD54open accessLICENSElicense.txtlicense.txttext/plain; charset=utf-814828https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/2831/5/license.txt2f9959eaf5b71fae44bbf9ec84150c7aMD55open accessTEXTfirmadaDERECHOS DE AUTOR TG 2021ValentinaVergara.pdf.txtfirmadaDERECHOS DE AUTOR TG 2021ValentinaVergara.pdf.txtExtracted texttext/plain1330https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/2831/6/firmadaDERECHOS%20DE%20AUTOR%20TG%202021ValentinaVergara.pdf.txt6a3846559aaaad30aff5d828aaab83a8MD56metadata only accessValentina Vergara Vanegas Presentación Tesis de grado final pdf.pdf.txtValentina Vergara Vanegas Presentación Tesis de grado final pdf.pdf.txtExtracted texttext/plain10350https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/2831/8/Valentina%20Vergara%20Vanegas%20Presentaci%c3%b3n%20Tesis%20de%20grado%20final%20pdf.pdf.txt334e0ee1367f1665d1da3a52ea13cdb5MD58open accessFormato decanatura 2.pdf.txtFormato decanatura 2.pdf.txtExtracted texttext/plain1https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/2831/10/Formato%20decanatura%202.pdf.txt68b329da9893e34099c7d8ad5cb9c940MD510metadata only accessTHUMBNAILfirmadaDERECHOS DE AUTOR TG 2021ValentinaVergara.pdf.jpgfirmadaDERECHOS DE AUTOR TG 2021ValentinaVergara.pdf.jpgGenerated Thumbnailimage/jpeg10878https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/2831/7/firmadaDERECHOS%20DE%20AUTOR%20TG%202021ValentinaVergara.pdf.jpg2d11c3e58ca224da3e58ab50a4636d09MD57metadata only accessValentina Vergara Vanegas Presentación Tesis de grado final pdf.pdf.jpgValentina Vergara Vanegas Presentación Tesis de grado final pdf.pdf.jpgGenerated Thumbnailimage/jpeg10196https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/2831/9/Valentina%20Vergara%20Vanegas%20Presentaci%c3%b3n%20Tesis%20de%20grado%20final%20pdf.pdf.jpgbb05eddbccc745988b4686c38588e1b6MD59open accessFormato decanatura 2.pdf.jpgFormato decanatura 2.pdf.jpgGenerated Thumbnailimage/jpeg9177https://repositorio.unicolmayor.edu.co/bitstream/unicolmayor/2831/11/Formato%20decanatura%202.pdf.jpgf957706ed46e826f36a21449284c68beMD511metadata only accessunicolmayor/2831oai:repositorio.unicolmayor.edu.co:unicolmayor/28312021-09-10 03:00:19.167An error occurred on the license name.|||https://creativecommons.org/licenses/by-nc-sa/4.0/metadata only accessBiblioteca Digital Unicolmayorrepositorio@unicolmayor.edu.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

Publicaciones similares